Lunch and Learn: Practical considerations when prescribing SGLT2 inhibitors in primary care
Join Dr Kevin Fernando and Dr Sarah Davies as they discuss the updates to the SGLT2 inhibitor prescribing tool, created by the Improving Diabetes Steering Committee.
This promotional session is sponsored and organised by A. Menarini Farmaceutica Internazionale SRL (Menarini) and for UK healthcare professionals only. Menarini products may be discussed. Prescribing information and adverse event reporting will be available at the symposium.